Literature DB >> 9101628

Positive screening tests for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic.

J R Schwebke1, R Sadler, J M Sutton, E W Hook.   

Abstract

BACKGROUND AND OBJECTIVES: Patients attending sexually transmitted disease (STD) clinics are frequently screened for gonorrhea and chlamydial infection. To determine the efficiency of these screening efforts as a component of STD control, we evaluated treatment outcomes of patients with positive cultures who had not received presumptive treatment at their initial visit. GOALS: To determine the treatment outcomes of patients screened for STDs who have positive test results. STUDY
DESIGN: Retrospective chart review of the computerized medical record.
RESULTS: Between January 1, 1994 and June 30, 1995, 24,823 patients were tested for gonorrhea, of whom 19.3% (4791) had positive cultures. Of patients with positive gonorrhea cultures, 564 (11.8%) had positive screening cultures and did not receive therapy at the time of evaluation. Similarly, screening chlamydial cultures were positive in 1539 (10.9%) of 14,162 patients screened for chlamydial infection. Forty-four percent (677) of these did not receive presumptive treatment for chlamydial infection at their initial visit. Overall, 20% of patients with positive cultures failed to return to the clinic for treatment within 30 days of screening. Of those who did return, 30% did so only after at least 2 weeks had elapsed.
CONCLUSIONS: A substantial proportion of patients with positive screening tests for gonorrhea and chlamydial infection fail to comply with follow-up recommendations and thus are likely to remain infectious. Methods must be sought to enhance patient compliance with follow-up of test results and treatment if indicated.

Entities:  

Mesh:

Year:  1997        PMID: 9101628     DOI: 10.1097/00007435-199704000-00001

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  20 in total

1.  Clinic-based evaluation of a rapid point-of-care test for detection of Chlamydia trachomatis in specimens from sex workers in Escuintla, Guatemala.

Authors:  M Sabidó; G Hernández; V González; X Vallès; A Montoliu; J Figuerola; V Isern; B Viñado; L Figueroa; J Casabona
Journal:  J Clin Microbiol       Date:  2008-12-03       Impact factor: 5.948

2.  Evaluation of the rapid BioStar optical immunoassay for detection of Chlamydia trachomatis in adolescent women.

Authors:  Claudiu I Bandea; Emilia H Koumans; Mary K Sawyer; Jason Dover; Angelica O'Connor; John R Papp; Elizabeth R Unger; Jim Braxton; Carolyn M Black
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

3.  Time to treatment for women with chlamydial or gonococcal infections: a comparative evaluation of sexually transmitted disease clinics in 3 US cities.

Authors:  David Wong; Stuart M Berman; Bruce W Furness; Robert A Gunn; Melanie Taylor; Thomas A Peterman
Journal:  Sex Transm Dis       Date:  2005-03       Impact factor: 2.830

4.  Decision analysis: point-of-care Chlamydia testing vs. laboratory-based methods.

Authors:  Geoffrey R Swain; Roberta A McDonald; John R Pfister; M Stephen Gradus; Gerald V Sedmak; Ajaib Singh
Journal:  Clin Med Res       Date:  2004-02

5.  Patterns of point-of-care test use among obstetricians and gynaecologists in the US.

Authors:  Anne M Rompalo; Neko Castleberry; Lea Widdice; Jay Schulkin; Charlotte A Gaydos
Journal:  Sex Health       Date:  2018-07       Impact factor: 2.706

6.  Perceptions of an ideal point-of-care test for sexually transmitted infections--a qualitative study of focus group discussions with medical providers.

Authors:  Yu-Hsiang Hsieh; M Terry Hogan; Mathilda Barnes; Mary Jett-Goheen; Jill Huppert; Anne M Rompalo; Charlotte A Gaydos
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

7.  Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting.

Authors:  Wei Huang; Charlotte A Gaydos; Mathilda R Barnes; Mary Jett-Goheen; Diane R Blake
Journal:  Sex Transm Infect       Date:  2012-09-14       Impact factor: 3.519

8.  Applying a mixed-integer program to model re-screening women who test positive for C. trachomatis infection.

Authors:  Guoyu Tao; Bartholomew K Abban; Thomas L Gift; Guantao Chen; Kathleen L Irwin
Journal:  Health Care Manag Sci       Date:  2004-05

9.  Point-of-care tests for sexually transmissible infections: what do 'end users' want?

Authors:  Anne M Rompalo; Yu-Hsiang Hsieh; Terry Hogan; Mathilda Barnes; Mary Jett-Goheen; Jill S Huppert; Charlotte A Gaydos
Journal:  Sex Health       Date:  2013-12       Impact factor: 2.706

10.  Evaluation of the Biostar Chlamydia OIA assay with specimens from women attending a sexually transmitted disease clinic.

Authors:  M S Pate; P B Dixon; K Hardy; M Crosby; E W Hook
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.